Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants
Clinical trial NCT04301310 · WITHDRAWN
Trial details
- NCT number
- NCT04301310
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-09
- Primary completion
- 2020-03-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.